Abstract:Tumor radioresistance, or the lack of control of certain tumors with this treatment, can result in locoregional recurrence; therefore, there is great interest in understanding the underlying biology and developing strategies to overcome this problem. MicroRNAs (miRNAs, miRs) are small non‐coding RNAs that regulate gene expression at the post‐transcriptional level and participate in cancer invasion, progression, metastasis, and therapeutic resistance. Emerging evidence indicates that miRNAs play a critical role in modulating key cellular pathways that mediate response to radiation, influencing radiosensitivity of cancer cells through interaction with other biological processes such as cell cycle checkpoints, apoptosis, autophagy, epithelialmesenchymal transition, and cancer stem cells. Today, most studies on patient data report different, results on the miRNAs evaluated for each tumor type, highlighting miR‐106b whose overexpression can determine radioresistance both in vitro and in vivo by inhibiting apoptosis and promotion of cell proliferation. The objective of this study was to find the signaling pathways involved with miR‐106b‐mediated radioresistance. CRC gene expression data sets were collected from the public database, The Cancer Genome Atlas (TCGA). In addition, web‐based tools were used to explore TCGA data, specifically that developed by the Memorial Sloan Kettering Cancer Center (MSK) cBioPortal for Cancer Genomics. The public site cBioPortal is hosted at the MSK Molecular Oncology Center, in which the term “colorectal cancer” was searched and 12 studies were selected, creating a single combined study which has 4341 patients and 4488 samples, within which the search for miR‐106b was carried out and the signaling pathways involved with the expression mediated by this miRNA were obtained. The following signaling pathways involved with miR‐106b were obtained: WNT, TP53, TGF‐Beta, RTK‐RAS, PI3K, NRF2, NOTCH, MYC, HIPPO, and its influence on the cell cycle was also noted. miRNAs have been shown to play an important role in the regulation of CRC radio resistance, by controlling various signaling pathways, including cell cycle, proliferation, apoptosis, and DNA damage repair. Furthermore, these results are consistent with recent data that have shown that selective modulation of miRNA activity can improve the response to radiotherapy, providing an innovative antitumor approach based on miRNA‐related gene therapy. Therefore, miRNAs could also serve as targets for the development of new therapeutic strategies to overcome radiation resistance in CRC.

MicroRNA-298 determines the radio-resistance of colorectal cancer cells by directly targeting human dual-specificity tyrosine(Y)-regulated kinase 1A

A Genome-Scale CRISPR Knock-Out Screen Identifies MicroRNA-5197-5p As a Promising Radiosensitive Biomarker in Colorectal Cancer.

Downregulation of miR-423-5p Contributes to the Radioresistance in Colorectal Cancer Cells

MiR-29a Regulates Radiosensitivity in Human Intestinal Cells by Targeting PTEN Gene

Downregulation of Mir-1 in Colorectal Cancer Promotes Radioresistance and Aggressive Phenotypes.

MiR-7-5p/KLF4 Signaling Inhibits Stemness and Radioresistance in Colorectal Cancer.

Role of Mir-100 in the Radioresistance of Colorectal Cancer Cells

MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.

MicroRNA-221 and -222 regulate radiation sensitivity by targeting the PTEN pathway.

Inhibition of ATG12-mediated autophagy by miR-214 enhances radiosensitivity in colorectal cancer

Circ_0067835 Knockdown Enhances the Radiosensitivity of Colorectal Cancer by miR-296-5p/IGF1R Axis

Signaling Pathways Associated with miR‐106b mediated Radioresistance in the Treatment of Colorectal Cancer

Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro

Radiation-induced Mir-208A Increases the Proliferation and Radioresistance by Targeting P21 in Human Lung Cancer Cells.

miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1

MicroRNA-204 modulates colorectal cancer cell sensitivity in response to 5-fluorouracil-based treatment by targeting high mobility group protein A2

RWR-algorithm-based dissection of microRNA-506-3p and microRNA-140-5p as radiosensitive biomarkers in colorectal cancer

miR-4443 promotes radiation resistance of esophageal squamous cell carcinoma via targeting PTPRJ

Mechanisms of Microrna Action in Rectal Cancer Radiotherapy

miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells.

Upregulation of Microrna-98 Increases Radiosensitivity in Esophageal Squamous Cell Carcinoma